arsenalbio | Arsenal Bio • Engineering Hope

Keyword	CPC	PCC	Volume	Score	Length of keyword
arsenalbio	1.03	0.1	844	50	10

Keyword	CPC	PCC	Volume	Score
arsenalbio	1.51	0.3	5944	70
arsenalbio linkedin	1.12	0.1	1532	57
arsenal biosciences	0.35	0.7	2125	18
arsenalbio twitter	1.52	0.6	6462	21
arsenalbio stock	1.6	0.7	8340	80
arsenalbio ab-1015	0.44	0.7	1514	47
arsenalbio funding	1.26	0.6	3231	95
arsenalbio bms	1.47	0.2	7309	48
arsenalbio logo	0.29	0.5	4824	65
arsenalbio ab-2100	1.95	0.7	5379	5
arsenalbio careers	0.3	0.1	3002	46
arsenalbio facebook	1.96	0.7	4304	21
arsenalbio pipeline	0.14	0.7	5910	68
arsenalbio glassdoor	0.35	0.5	7023	70

Search Results related to arsenalbio on Search Engine

Arsenal Bio • Engineering Hope
arsenalbio.com

https://arsenalbio.com/

WEBBold Ideas. Breakthrough Discoveries. With our programmable and computationally driven approach, our team is engineering medicines with the goal to attack cancer’s inherent multi-faceted nature and overcome the challenges of addressing solid tumors with cell therapy. Our Technology.

DA: 83 PA: 12 MOZ Rank: 22

About • Arsenal Bio
arsenalbio.com

https://arsenalbio.com/about/

WEBArsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on solid tumor cell therapies to defeat cancer. With our programmable and computationally driven approach, we aim for enhanced and broader activity and safety profile.

DA: 1 PA: 96 MOZ Rank: 6

Pipeline • Arsenal Bio
arsenalbio.com

https://arsenalbio.com/pipeline/

WEBArsenalBio and Genentech are deploying synergistic capabilities to study effective T cell-based modifications and develop new understandings of their effects through preclinical analysis. Both companies will leverage these learnings in the development of future therapeutic candidates.

DA: 21 PA: 17 MOZ Rank: 50

Technology • Arsenal Bio
arsenalbio.com

https://arsenalbio.com/technology/

WEBArsenalBio is engineering enhanced CAR T cell therapies by creating new synthetic modules and incorporating them into T cells to program them to execute new behaviors, much in the same way that smartphones get new features as new versions are released. Each Product in pipeline is built upon a growing cell therapy feature set.

DA: 61 PA: 56 MOZ Rank: 30

Arsenal Biosciences Announces Presentation of Four Abstracts …
arsenalbio.com

https://arsenalbio.com/2024/04/05/arsenal-biosciences-announces-presentation-of-four-abstracts-at-aacr-annual-meeting-highlighting-new-car-t-focused-research/

WEBApr 5, 2024. Arsenal Biosciences Announces Presentation of Four Abstracts at AACR Annual Meeting Highlighting New CAR T-Focused Research. Company to share preclinical data on the utility of engineered T cells intended for the treatment of ovarian, kidney, and other solid tumor cancers.

DA: 78 PA: 25 MOZ Rank: 76

Arsenal Bio
arsenalbio.com

https://www.arsenalbio.com/?ref=levels.fyi

WEBArsenalBio was founded to discover, develop and commercialize curative immune cell therapies

DA: 2 PA: 88 MOZ Rank: 30

Arsenal Biosciences, Inc. | LinkedIn
linkedin.com

https://www.linkedin.com/company/arsenalbio

WEBAbout us. ArsenalBiosciences, Inc., is a privately held, clinical stage programmable cell therapy company focused on the realization of solid tumor cell therapy to defeat cancer. Our discovery ...

DA: 59 PA: 40 MOZ Rank: 61

News • Arsenal Bio
arsenalbio.com

https://arsenalbio.com/news/

WEBJan 5, 2023 · ArsenalBio Named to Endpoints 11 List as One of the Top Biotechs of 2023. Read More. May 16, 2023.

DA: 68 PA: 59 MOZ Rank: 40

ArsenalBio Announces Multi-Program Discovery Collaboration …
businesswire.com

https://www.businesswire.com/news/home/20210107005234/en/ArsenalBio-Announces-Multi-Program-Discovery-Collaboration-with-Bristol-Myers-Squibb-to-Advance-Next-Generation-T-cell-Therapies-for-Solid-Tumors

WEBJan 7, 2021 · SOUTH SAN FRANCISCO, Calif.-- ( BUSINESS WIRE )--ArsenalBio, a privately held programmable cell therapy company, today announced the formation of a multi-year discovery collaboration with Bristol...

DA: 6 PA: 11 MOZ Rank: 6

ArsenalBio Launches With $85 Million Series A Financing to
businesswire.com

https://www.businesswire.com/news/home/20191017005246/en/ArsenalBio-Launches-With-85-Million-Series-A-Financing-to-Advance-New-Paradigm-to-Discover-and-Develop-Immune-Cell-Therapies

WEBOct 17, 2019 · SOUTH SAN FRANCISCO, Calif.-- ( BUSINESS WIRE )--ArsenalBio makes its debut today backed by $85 million Series A financing to build a programmable cell therapy company to create highly effective...

DA: 49 PA: 55 MOZ Rank: 89